MENU
UTHR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
United Therapeutics (UTHR) Earnings Date & Reports
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs... Show more
Industry: #Pharmaceuticals Other
A.I. Advisor
published Earnings
UTHR is expected to report earnings to fall 11.14% to $6.46 per share on November 04
Q3'26
Est.
$6.46
Q2'26
Beat
by $0.18
Q1'26
Missed
by $1.17
Q4'25
Beat
by $0.60
Q3'25
Missed
by $0.16
The last earnings report on August 05 showed earnings per share of $7.27, beating the estimate of $7.09. With 218.25K shares outstanding, the current market capitalization sits at 20.83B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products
Industry PharmaceuticalsGeneric
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1400
Web
https://www.unither.com